ABEV Stock Analysis: Ambev | NYSE
Beverages - Brewers | NYSE, USA | Market Cap: 41.162m USD | 12M Return: 23.7% | US02319V1035 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 73.4M
EPS Trend: -36.9%
Qual. Beats: 0
Rev. Trend: 72.7%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Ambev S.A. is a major Latin American beverage producer that manufactures, distributes, and sells beer, draft beer, soft drinks, malt, and other beverages across Brazil, Central America and the Caribbean, Latin America South, and Canada. Its brand portfolio includes well-known names such as Brahma, Skol, Antarctica, Quilmes, and Guaraná Antarctica, spanning beer, ready-to-drink cocktails, soft drinks, water, teas, and isotonic drinks. The company sells its products to distributors, supermarkets, and retailers through an extensive regional distribution network.
Founded in 1853 and headquartered in São Paulo, Brazil, Ambev operates as a subsidiary of Interbrew International B.V., placing it within the global AB InBev group. Listed in the GICS Consumer Staples sector under the Brewers sub-industry, the company benefits from the defensive characteristics of the beverages industry, including relatively stable demand for beer and soft drinks, and operates a multi-category portfolio that diversifies revenue across alcoholic and non-alcoholic segments.
- Brazilian beer volumes rise on premium brand mix shift
- BRL depreciation pressures USD-denominated ADR earnings
- Brazil excise tax hikes threaten beverage margin expansion
| Net Income: 15.7b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 2.80 > 1.0 |
| NWC/Revenue: 2.73% < 20% (prev 5.93%; Δ -3.20% < -1%) |
| CFO/TA 0.20 > 3% & CFO 28.8b > Net Income 15.7b |
| Net Debt (-16.8b) to EBITDA (29.8b): -0.57 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (15.5b) vs 12m ago -1.24% < -2% |
| Gross Margin: 51.78% > 18% (prev 51.77%; Δ 0.01% > 0.5%) |
| Asset Turnover: 63.06% > 50% (prev 64.28%; Δ -1.22% > 0%) |
| Interest Coverage Ratio: 8.68 > 6 (EBIT TTM 23.1b / Interest Expense TTM 2.66b) |
| A: 0.02 (Total Current Assets 43.2b - Total Current Liabilities 40.7b) / Total Assets 142b |
| B: 0.08 (Retained Earnings 11.2b / Total Assets 142b) |
| C: 0.16 (EBIT TTM 23.1b / Avg Total Assets 141b) |
| D: 1.81 (Book Value of Equity 90.9b / Total Liabilities 50.1b) |
| Altman-Z'' = 3.37 = A |
| DSRI: 0.91 (Receivables 7.93b/8.88b, Revenue 89.0b/90.5b) |
| GMI: 1.00 (GM 51.77% / 51.78%) |
| AQI: 1.00 (AQ_t 0.52 / AQ_t-1 0.51) |
| SGI: 0.98 (Revenue 89.0b / 90.5b) |
| TATA: -0.09 (NI 15.7b - CFO 28.8b) / TA 142b) |
| Beneish M = -3.12 (Cap -4..+1) = AA |
As of November 10, 2026, the stock is trading at USD 2.79 with a total of 20,500,974 shares traded. Over the past week, the price has changed by +4.89%, over one month by -13.35%, over three months by -6.88% and over the past year by +23.74%.
Current recommended Stop Loss: 2.60 (which is 6.8% or 1.9 ATR below the current price).
Ambev has received a consensus analysts rating of 2.91. Therefore, it is recommended to hold ABEV.
- StrongBuy: 1
- Buy: 2
- Hold: 5
- Sell: 1
- StrongSell: 2
| Analysts Target Price | 3.3 | 18.3% |
Market Cap BRL = 225b (41.2b USD * 5.4592 USD.BRL)
P/E Trailing = 14.0526
P/E Forward = 13.1062
P/S = 0.4624
P/B = 2.6087
P/EG = 1.8944
Revenue TTM = 89.0b BRL
EBIT TTM = 23.1b BRL
EBITDA TTM = 29.8b BRL
Long Term Debt = 216.1m BRL (from longTermDebt, last quarter)
Short Term Debt = 997.1m BRL (from shortTermDebt, last quarter)
Debt = 5.08b BRL (from shortLongTermDebtTotal, last quarter) + Leases 2.36b
Net Debt = -16.8b BRL (calculated: Debt 5.08b - CCE 21.9b)
Enterprise Value = 208b BRL (225b + Debt 5.08b - CCE 21.9b)
Interest Coverage Ratio = 8.68 (Ebit TTM 23.1b / Interest Expense TTM 2.66b)
EV/FCF = 8.42x (Enterprise Value 208b / FCF TTM 24.7b)
FCF Yield = 11.88% (FCF TTM 24.7b / Enterprise Value 208b)
FCF Margin = 27.74% (FCF TTM 24.7b / Revenue TTM 89.0b)
Net Margin = 17.69% (Net Income TTM 15.7b / Revenue TTM 89.0b)
Gross Margin = 51.78% ((Revenue TTM 89.0b - Cost of Revenue TTM 42.9b) / Revenue TTM)
Gross Margin QoQ = 50.97% (prev 51.86%)
Tobins Q-Ratio = 1.47 (Enterprise Value 208b / Total Assets 142b)
Interest Expense / Debt = 52.46% (Interest Expense 2.66b / Debt 5.08b)
Taxrate = 20.51% (4.19b / 20.5b)
NOPAT = 18.4b (EBIT 23.1b * (1 - 20.51%))
Current Ratio = 1.06 (Total Current Assets 43.2b / Total Current Liabilities 40.7b)
Debt / Equity = 0.06 (Debt 5.08b / totalStockholderEquity, last quarter 90.9b)
Debt / EBITDA = -0.57 (Net Debt -16.8b / EBITDA 29.8b)
Debt / FCF = -0.68 (Net Debt -16.8b / FCF TTM 24.7b)
Total Stockholder Equity = 89.3b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.16% (Net Income 15.7b / Total Assets 142b)
RoE = 17.63% (Net Income TTM 15.7b / Total Stockholder Equity 89.3b)
RoCE = 25.82% (EBIT 23.1b / Capital Employed (Equity 89.3b + L.T.Debt 216.1m))
RoIC = 18.86% (NOPAT 18.4b / Invested Capital 97.4b)
WACC = 6.73% (E(225b)/V(230b) * Re(6.88%) + (debt cost/tax rate unavailable))
Discount Rate = 6.88% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.30 | Cagr: -0.94%
[DCF] Terminal Value 77.97% ; FCFF base≈23.1b ; Y1≈26.4b ; Y5≈38.9b
[DCF] Fair Price = 39.07 (EV 585b - Net Debt -16.8b = Equity 602b / Shares 15.4b; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -36.95 | EPS CAGR: -2.80% | SUE: 0.0 | # QB: 0
Revenue Correlation: 72.69 | Revenue CAGR: 4.52% | SUE: -0.01 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.05 | Chg30d=+0.00% | Revisions=+0% | Analysts=1
EPS current Year (2026-12-31): EPS=0.20 | Chg30d=-0.15% | Revisions=+17% | GrowthEPS=+11.5% | GrowthRev=+2.6%
EPS next Year (2027-12-31): EPS=0.21 | Chg30d=-1.03% | Revisions=+50% | GrowthEPS=+5.9% | GrowthRev=+5.2%
[Analyst] Revisions Ratio: +44% (up=5, down=1)